Article
Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.
Molecular genetics and metabolism - 1 Jul 2013
Comeaux Matthew S, Wang Jing, Wang Guoli, Kleppe Soledad, Zhang Victor Wei, Schmitt Eric S, Craigen William J, Renaud Deborah, Sun Qin, Wong Lee-Jun
Abstract excerpt
Cerebral creatine deficiency syndromes (CCDS) are a group of inborn errors of creatine metabolism that involve AGAT and GAMT for creatine biosynthesis disorders and SLC6A8 for creatine transporter (CT1) deficiency. Deficiencies in the three enzymes can be distinguished by intermediate metabolite levels, and a definitive diagnosis relies on the presence of deleterious mutations in the causative genes. Mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
